Tomomi Furihata News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tomomi furihata. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tomomi Furihata Today - Breaking & Trending Today

Intracranial Intrigue: Unmasking the Mutant Genes Behind Brain Aneurysms

Researchers at the RIKEN Center for Brain Science (CBS) in Japan have discovered a set of related mutations that lead to intracranial aneurysms weakened blood vessels in the brain that can burst at any time. The mutations all appear to act on the same biological signaling pathway, and the researcher ....

Xiaoning Sun , Masato Nakafuku , Motoo Nagane , Atsuko Nakanishi Ozeki , Nobuhito Saito , Tadafumi Kato , Hiroyasu Kamiyama , Masashi Fujita , Rokuya Tanikawa , Nakao Ota , Shigeo Okabe , Yoichiro Kamatani , Tomomi Furihata , Hiroyuki Kamiguchi , Koichi Matsuda , Kosumo Noda , Junji Shibahara , Kenjiro Kosaki , Yasuyuki Shima , Hirofumi Nakatomi , Rieko Oyama , Hirochika Kawakami , Hiroki Kurihara , Nobuko Mataga , Satoru Takahashi , Toru Tanaka ,

Stroke of Luck: Therapeutic Target Discovered in Blood–Brain Barrier


 
Scientists from Japan and the United States have identified a new mechanism of blood-brain barrier degradation in the post-stroke brain, involving acrolein-induced modifications of proheparanase. This discovery could lead to the production of newer and more effective drugs for stroke-related disorders. Credit: Toubibe from Pixabay
Read Time:
The blood-brain barrier prevents immune cells from circulating freely in the brain, and the breakdown of its function is a major cause of post-stroke inflammation. Now, for the first time, researchers have identified how a toxic stroke byproduct, acrolein, could activate the barrier-degrading enzyme proheparanase (proHPSE). The research group has discovered that proHPSE degrades the glycocalyx within the post-stroke brain s blood vessels, providing hope for new and effective therapeutics against post-stroke inflammation. ....

United States , Kazuei Igarashi , Tomomi Furihata , Takehiro Suzuki , Toshihiko Toida , Kyohei Higashi , Naoshi Dohmae , Robertj Linhardt , Tokyo University Of Pharmacy , Amine Pharma Research Institute , Rensselaer Polytechnic Institute , Life Sciences , Tokyo University Of Science , Chiba University , Associate Professor Kyohei Higashi , Tokyo University , Biological Chemistry , Sustainable Resource Science , ஒன்றுபட்டது மாநிலங்களில் , டோக்கியோ பல்கலைக்கழகம் ஆஃப் மருந்தகம் , அமீன் பார்மா ஆராய்ச்சி நிறுவனம் , ரென்சீலர் பாலிடெக்நிக் நிறுவனம் , வாழ்க்கை அறிவியல் , டோக்கியோ பல்கலைக்கழகம் ஆஃப் அறிவியல் , சிபா பல்கலைக்கழகம் , டோக்கியோ பல்கலைக்கழகம் ,